Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - KERYX BIOPHARMACEUTICALS INC | Financial_Report.xls |
| EX-32.1 - EX-32.1 - KERYX BIOPHARMACEUTICALS INC | d846100dex321.htm |
| EX-23.1 - EX-23.1 - KERYX BIOPHARMACEUTICALS INC | d846100dex231.htm |
| EX-32.2 - EX-32.2 - KERYX BIOPHARMACEUTICALS INC | d846100dex322.htm |
| EX-31.1 - EX-31.1 - KERYX BIOPHARMACEUTICALS INC | d846100dex311.htm |
| EX-31.2 - EX-31.2 - KERYX BIOPHARMACEUTICALS INC | d846100dex312.htm |
| EX-10.16 - EX-10.16 - KERYX BIOPHARMACEUTICALS INC | d846100dex1016.htm |
| 10-K - FORM 10-K - KERYX BIOPHARMACEUTICALS INC | d846100d10k.htm |
Exhibit 21.1
Keryx Biopharmaceuticals, Inc.
List of Subsidiaries
| Name of Subsidiary |
State/Jurisdiction of Incorporation | |
| ACCESS Oncology, Inc. |
Delaware | |
| Accumin Diagnostics, Inc. |
Delaware | |
| AOI Pharma, Inc. |
Delaware | |
| AOI Pharmaceuticals, Inc. |
Delaware | |
| Neryx Biopharmaceuticals, Inc. |
Delaware | |
| Online Collaborative Oncology Group, Inc. |
Delaware | |
| Keryx Biomedical Technologies Ltd. |
Israel | |
| Keryx (Israel) Ltd. |
Israel | |
| Keryx Biopharma UK Ltd. |
United Kingdom |